EuBiologics Co.,Ltd. Company Profile - South Korea | Financials & Key Executives

The Company is a Korea-based company principally engaged in manufacture and distribution of biopharmaceuticals. The Company also engaged in development of biopharmaceuticals and vaccine. The Company was established on March 10, 2010. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on January 24, 2017.

Headquarters
8F, Seongdo Bldg., 207, Dosan-Daero, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the EuBiologics Co.,Ltd. report to view the information.

Website: http://www.eubiologics.com

Basic Information

Total Employees:

Purchase the EuBiologics Co.,Ltd. report to view the information.

Outstanding Shares:

Purchase the EuBiologics Co.,Ltd. report to view the information.

Registered Capital:

Purchase the EuBiologics Co.,Ltd. report to view the information.

Financial Auditors:

Purchase the EuBiologics Co.,Ltd. report to view the information.

Incorporation Date:

March 10, 2010

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Ownership Details

Purchase this report to view the information.

9.9%

Purchase this report to view the information.

8.4%

Purchase this report to view the information.

6.3%

Subsidiaries

(주)벡스퍼트

Company Performance

Net sales revenue

Net Profit (Loss) for the Period

Net Profit Margin

Financial values in the chart are available after EuBiologics Co.,Ltd. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

39.4%▲

Total operating revenue

39.4%▲

Operating profit (EBIT)

N/A

EBITDA

403.33%▲

Net Profit (Loss) for the Period

N/A

Total assets

6.81%▲

Total equity

5.37%▲

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Debt to Equity Ratio

-1.26%▼

Quick Ratio

0.58%▲

Cash Ratio

0.07%▲

EuBiologics Co.,Ltd. (South Korea)

Similar companies